Effect of Kaempferol on Tacrolimus-Induced Nephrotoxicity and Calcineurin B1 Expression Level in Animal Model

Ahmed Shaker Ali,1,2 Abdullah Saddah Almalki,1,3 Basma Tarek Alharthy1 1Department of Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 2Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt; 3Department of Pharmacy, Ajyad Hospital, Mini...

Full description

Bibliographic Details
Main Authors: Ali AS, Almalki AS, Alharthy BT
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:Journal of Experimental Pharmacology
Subjects:
Online Access:https://www.dovepress.com/effect-of-kaempferol-on-tacrolimus-induced-nephrotoxicity-and-calcineu-peer-reviewed-fulltext-article-JEP
_version_ 1819029442231533568
author Ali AS
Almalki AS
Alharthy BT
author_facet Ali AS
Almalki AS
Alharthy BT
author_sort Ali AS
collection DOAJ
description Ahmed Shaker Ali,1,2 Abdullah Saddah Almalki,1,3 Basma Tarek Alharthy1 1Department of Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 2Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt; 3Department of Pharmacy, Ajyad Hospital, Ministry of Health, Riyadh, Saudi ArabiaCorrespondence: Abdullah Saddah Almalki Makkah 24268 – 9382, Kingdom of Saudi ArabiaTel +966 126401000 - Ext 20151Fax +966 126400855Email a1410s@hotmail.comBackground: The kidneys are considered one of the most susceptible organs for adverse drug effects, particularly in post-transplant conditions. Tacrolimus (FK506), a calcineurin inhibitor immunosuppressant, is an essential component in the transplantation regimen. Despite that, nephrotoxicity is a severe drawback for its chronic utilization, where oxidative stress might be implicated. Kaempferol (KMF) is a natural flavonoid that has many adaptable biological activities, including antioxidant action.Objective: Exploring the KMF protective effect on FK506-induced nephrotoxicity and the underlying role of calcineurin B1.Methods: Twenty-four male albino-Wistar rats were randomly divided into three equal groups. The control group received solvents: propylene glycol, i.p. and 0.5% carboxymethyl cellulose, PO; FK506 group was injected with FK506 (0.6 mg/kg, i.p.), and FK506+KMF group was given FK506 (0.6 mg/kg, i.p.) and KMF (10 mg/kg, PO). The treatment regimen for all groups was once daily for 30 days. ELISA technique applied for measuring FK506 trough level and nephrotoxicity biomarkers in serum (cystatin C and urea) on days 15 and 30, and in kidney tissue homogenate (MDA and calcineurin B1) on day 30.Results: In FK506-treated rats, the FK506 trough level was 7.84 ± 1.31 ug/l on day 15 and 9.54 ± 1.45 ug/l on day 30. FK506 use has significantly (P< 0.01) increased biomarkers levels of cystatin C (325% and 477%), urea (177% and 245%), MDA (1253%), except calcineurin B1 that has decreased (97%). The KMF combination has resulted in a significant reduction in the FK506 trough level by day 30 (6.79 ± 1.35 ug/l, P< 0.01). KMF has significantly ameliorated the levels of cystatin C (46% and 73%, P< 0.001), urea (38% and 68%, P< 0.001), MDA (75%, P< 0.001), and calcineurin B1 (1833%, P< 0.05).Conclusion: Oxidative stress and calcineurin B1 are contributing factors in FK506-induced nephrotoxicity. Hence, inhibition of calcineurin enzyme is not limited to the immune cells. KMF could be a novel nephroprotective antioxidant.Keywords: FK506, kaempferol, calcineurin B1, nephrotoxicity, biomarkers
first_indexed 2024-12-21T06:14:19Z
format Article
id doaj.art-bd6bc005900e4cdab06b219d5a370dad
institution Directory Open Access Journal
issn 1179-1454
language English
last_indexed 2024-12-21T06:14:19Z
publishDate 2020-10-01
publisher Dove Medical Press
record_format Article
series Journal of Experimental Pharmacology
spelling doaj.art-bd6bc005900e4cdab06b219d5a370dad2022-12-21T19:13:27ZengDove Medical PressJournal of Experimental Pharmacology1179-14542020-10-01Volume 1239740758559Effect of Kaempferol on Tacrolimus-Induced Nephrotoxicity and Calcineurin B1 Expression Level in Animal ModelAli ASAlmalki ASAlharthy BTAhmed Shaker Ali,1,2 Abdullah Saddah Almalki,1,3 Basma Tarek Alharthy1 1Department of Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 2Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt; 3Department of Pharmacy, Ajyad Hospital, Ministry of Health, Riyadh, Saudi ArabiaCorrespondence: Abdullah Saddah Almalki Makkah 24268 – 9382, Kingdom of Saudi ArabiaTel +966 126401000 - Ext 20151Fax +966 126400855Email a1410s@hotmail.comBackground: The kidneys are considered one of the most susceptible organs for adverse drug effects, particularly in post-transplant conditions. Tacrolimus (FK506), a calcineurin inhibitor immunosuppressant, is an essential component in the transplantation regimen. Despite that, nephrotoxicity is a severe drawback for its chronic utilization, where oxidative stress might be implicated. Kaempferol (KMF) is a natural flavonoid that has many adaptable biological activities, including antioxidant action.Objective: Exploring the KMF protective effect on FK506-induced nephrotoxicity and the underlying role of calcineurin B1.Methods: Twenty-four male albino-Wistar rats were randomly divided into three equal groups. The control group received solvents: propylene glycol, i.p. and 0.5% carboxymethyl cellulose, PO; FK506 group was injected with FK506 (0.6 mg/kg, i.p.), and FK506+KMF group was given FK506 (0.6 mg/kg, i.p.) and KMF (10 mg/kg, PO). The treatment regimen for all groups was once daily for 30 days. ELISA technique applied for measuring FK506 trough level and nephrotoxicity biomarkers in serum (cystatin C and urea) on days 15 and 30, and in kidney tissue homogenate (MDA and calcineurin B1) on day 30.Results: In FK506-treated rats, the FK506 trough level was 7.84 ± 1.31 ug/l on day 15 and 9.54 ± 1.45 ug/l on day 30. FK506 use has significantly (P< 0.01) increased biomarkers levels of cystatin C (325% and 477%), urea (177% and 245%), MDA (1253%), except calcineurin B1 that has decreased (97%). The KMF combination has resulted in a significant reduction in the FK506 trough level by day 30 (6.79 ± 1.35 ug/l, P< 0.01). KMF has significantly ameliorated the levels of cystatin C (46% and 73%, P< 0.001), urea (38% and 68%, P< 0.001), MDA (75%, P< 0.001), and calcineurin B1 (1833%, P< 0.05).Conclusion: Oxidative stress and calcineurin B1 are contributing factors in FK506-induced nephrotoxicity. Hence, inhibition of calcineurin enzyme is not limited to the immune cells. KMF could be a novel nephroprotective antioxidant.Keywords: FK506, kaempferol, calcineurin B1, nephrotoxicity, biomarkershttps://www.dovepress.com/effect-of-kaempferol-on-tacrolimus-induced-nephrotoxicity-and-calcineu-peer-reviewed-fulltext-article-JEPfk506kaempferolcalcineurin b1nephrotoxicitybiomarkers
spellingShingle Ali AS
Almalki AS
Alharthy BT
Effect of Kaempferol on Tacrolimus-Induced Nephrotoxicity and Calcineurin B1 Expression Level in Animal Model
Journal of Experimental Pharmacology
fk506
kaempferol
calcineurin b1
nephrotoxicity
biomarkers
title Effect of Kaempferol on Tacrolimus-Induced Nephrotoxicity and Calcineurin B1 Expression Level in Animal Model
title_full Effect of Kaempferol on Tacrolimus-Induced Nephrotoxicity and Calcineurin B1 Expression Level in Animal Model
title_fullStr Effect of Kaempferol on Tacrolimus-Induced Nephrotoxicity and Calcineurin B1 Expression Level in Animal Model
title_full_unstemmed Effect of Kaempferol on Tacrolimus-Induced Nephrotoxicity and Calcineurin B1 Expression Level in Animal Model
title_short Effect of Kaempferol on Tacrolimus-Induced Nephrotoxicity and Calcineurin B1 Expression Level in Animal Model
title_sort effect of kaempferol on tacrolimus induced nephrotoxicity and calcineurin b1 expression level in animal model
topic fk506
kaempferol
calcineurin b1
nephrotoxicity
biomarkers
url https://www.dovepress.com/effect-of-kaempferol-on-tacrolimus-induced-nephrotoxicity-and-calcineu-peer-reviewed-fulltext-article-JEP
work_keys_str_mv AT alias effectofkaempferolontacrolimusinducednephrotoxicityandcalcineurinb1expressionlevelinanimalmodel
AT almalkias effectofkaempferolontacrolimusinducednephrotoxicityandcalcineurinb1expressionlevelinanimalmodel
AT alharthybt effectofkaempferolontacrolimusinducednephrotoxicityandcalcineurinb1expressionlevelinanimalmodel